Through a presentation, the Union minister was briefed regarding the evolving global scenario. He appreciated and congratulated the pharma companies for their invaluable contribution during the Covid pandemic in the country.
[File Photo]
Union Health Minister Mansukh Mandaviya, on Thursday, reviewed the status, and adequacy of Covid management drugs and production capacities with representatives of pharma companies so that the country is equipped to effectively handle any situation.
The meeting was taken in view of the spike in Covid-9 cases in some countries worldwide.
Through a presentation, the Union minister was briefed regarding the evolving global scenario. Mandaviya appreciated and congratulated the pharma companies for their invaluable contribution during the Covid pandemic in the country.
Advertisement
“India’s pharmaceutical industry is robust, resilient and responsive. It is due to their strength that we could not only meet our down demand during the pandemic but were also in a position to supply medicines to 150 countries,” he said. This was achieved without any fall in quality and no hike in the price of the medicines, he noted.
The pharma companies were asked to keep a close watch on the global supply chain scenario. They were also asked to closely monitor the production and availability of APIs as well as formulations of essential medicines for Covid management. They were told to ensure adequate stocks and availability of all drugs including Covid drugs in the supply chain up to the retail level.
The pharma companies hailed the timely review meeting chaired by the minister and assured their continued support. They expressed confidence that they will be able to manage the supply chain of Covid drugs.
Advertisement
